Lantheus to Showcase Innovations at Global Healthcare Conference
![Lantheus to Showcase Innovations at Global Healthcare Conference](https://investorshangout.com/images/blog/ihnews-Lantheus%20to%20Showcase%20Innovations%20at%20Global%20Healthcare%20Conference.jpg)
Lantheus to Present at the Morgan Stanley Annual Global Healthcare Conference
Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a leading radiopharmaceutical-focused company, is committed to enabling clinicians to find, fight, and follow disease to enhance patient outcomes. The company is excited to announce that Brian Markison, Chief Executive Officer, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference. The presentation is scheduled for 7:45 a.m. ET on an upcoming Wednesday in September.
Accessing the Presentation
Individuals interested in the live presentation can access it via a webcast. To attend, please visit the Investors section of the Company’s website at www.lantheus.com. After the live event concludes, a recording of the presentation will be made available on the company’s website, where it will remain for at least 30 days, allowing interested parties to catch up on the insights shared.
About Lantheus Holdings, Inc.
Lantheus is a pioneer in the field of radiopharmaceuticals, proudly delivering life-changing scientific solutions for disease detection and treatment. For over 65 years, Lantheus has dedicated itself to providing innovative radiopharmaceutical solutions that support healthcare professionals in their critical work. Headquartered in Massachusetts with additional offices in Canada and Sweden, Lantheus continuously strives to advance its offerings in the healthcare sector.
Company Leadership and Initiatives
Under the adept leadership of Brian Markison and a dedicated team, Lantheus is focused on leveraging scientific advancements to support clinicians. The company’s mission revolves around enhancing patient outcomes by ensuring that healthcare providers have access to the best tools and technologies needed to manage diseases effectively. This commitment is reflected in their ongoing research and engagement with healthcare partners to expand their product offerings.
Strategic Goals and Developments
Lantheus is always on the lookout for opportunities to enhance its service offerings. By continuing to invest in research and development, the company aims to introduce innovative solutions that address the evolving needs of healthcare professionals and patients alike. The planned presentation at the Morgan Stanley Conference is one of many initiatives that showcase Lantheus’s commitment to excellence in healthcare.
Connecting with Stakeholders
As part of its approach to engage with stakeholders, Lantheus prioritizes transparency and communication. The upcoming presentation is expected to provide valuable insights into the company’s strategic direction and technological advancements. By keeping stakeholders informed, Lantheus strengthens its relationships and reinforces its dedication to improving patient care.
Contact Information
For any inquiries related to the presentation or other company matters, interested parties can reach out to:
Mark Kinarney
Vice President, Investor Relations
Telephone: 978-671-8842
Email: ir@lantheus.com
Melissa Downs
Senior Director, External Communications
Telephone: 646-975-2533
Email: media@lantheus.com
Frequently Asked Questions
What is the significance of Lantheus attending the Global Healthcare Conference?
Lantheus's participation highlights its commitment to sharing advancements in radiopharmaceuticals and improving patient care.
When will Brian Markison present at the conference?
Brian Markison will present at 7:45 a.m. ET on a Wednesday in September.
How can I access the webcast of the presentation?
The webcast can be accessed through the Investors section of the Lantheus website at www.lantheus.com.
What is the focus of Lantheus as a company?
Lantheus focuses on enabling clinicians to Find, Fight, and Follow disease through innovative radiopharmaceutical solutions.
Who can I contact for more information about Lantheus?
For inquiries, you can contact Mark Kinarney or Melissa Downs through the provided contact information.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- KULR Technology Group Unveils New Investor Presentation
- Mortgage Rates Hit New Low, Boosting Home Applications
- Metabolism Assays Market to Hit USD 3.1 Billion Growth
- Alm. Brand A/S Trading Report by Executives and Related Parties
- Middlefield Canadian Income PCC Announces Latest NAV Details
- Columbus A/S Shares Transaction Notification and Management
- Pixalate Reveals Top Grossing CTV Apps for 2024
- Keywords Studios Plc: Recent Position Disclosure Update
- Understanding Retirement Strategies to Ensure Financial Security
- Super Micro Computer Faces Challenges Amid Stock Plunge